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Abstract
Background: High-frequency pallidal stimulation has been shown to improve various types of dystonia, including myoclonus-dystonia.
Case Report: We report a case of epsilon sarcoglycan mutation-negative myoclonus–dystonia with response to low-frequency bilateral pallidal stimulation.
Discussion: Low-frequency pallidal stimulation provides an effective means of treating various dystonias, regardless of genetic status, as in our case, as it provides
increased programming options with fewer adverse effects.
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Introduction
Myoclonus–dystonia (MD) is a genetically and phenotypically heter-
ogenous condition, which presents with myoclonus of proximal muscles
and dystonia, typically of the neck and arm.1 Most commonly, mutations
in the epsilon sarcoglycan (SGCE) gene are found but approximately
50% of cases do not have mutations in this gene.2 Deep brain stimula-
tion (DBS) can be effective in the treatment of MD, with most cases
reporting positive effects of pallidal stimulation.2 Although several reports
demonstrated improvement with high-frequency pallidal stimulation, we
report a case of SGCE mutation-negative MD whose myoclonus and
dystonia responded to low-frequency bilateral pallidal stimulation.
Case report
The patient is a 36-year-old female without any significant medical
or family history who presented to our movement disorders center
after 7 years of difficulty walking and myoclonus. Her family reported
that her walking difficulty began at the age of 14 years. Her symptoms
continued to progress, and she developed severe alcohol- responsive
myoclonus of the trunk and limbs, particularly of the right arm,
hyperextension of the legs, and bilateral foot drag and plantar flexion.
In addition, she developed adductor spasmodic dysphonia, tongue
protrusion, jaw-opening dystonia, and retro- and laterocollis. Dystonia
impaired ambulation, and negative myoclonus caused falls, resulting in
her use of a motorized wheelchair. The myoclonus interfered with her
right-hand movements, and she relied on her left for getting dressed
and eating. Failed medication trials included sodium oxybate (1.5
grams (GM) orally twice a day), topiramate (200 mg orally three times
a day), levetiracetam (500 mg orally twice a day), and clonazepam
(2 mg orally three times a day). Botulinum toxin injections of the lateral
pterygoids for jaw opening, genioglossus for tongue protrusion, and laryn-
geal injections for spasmodic dysphonia (SD) temporarily improved speech.
Pre-surgical mental status examination demonstrated normal lan-
guage, attention, and memory, and general neurologic examination
was likewise normal. On movement examination, she had a hoarse
voice, constant low-amplitude myoclonic jerks of the trunk and pelvis
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worsening with action and stress, no bradykinesia, mild bilateral inten-
tion tremor, and slight right laterocollis of about 5 degrees with
superimposed jerky retrocollis. She was able to stand with her arms
crossed. While walking, she had right plantarflexion and dragged the
right leg. The left leg was internally rotated. While pouring water, she
had right limb, truncal, and pelvic myoclonus. Both hands had myo-
clonic jerks while using utensils, but the jerks were more prominent on
the right. However, she was able to bring a fork to her mouth. Writing
triggered severe myoclonus of the right hand and both legs. There was
also a tight gripping of the pen while writing. Her pre-surgical Burke–
Fahn–Marsden Dystonia Rating Scale (BFMDS) was 76. The Unified
Myoclonus Scale was not performed but her initial Clinical Global
Improvement Scale (CGI) was 7. Genetic testing did not reveal an
SGCE mutation.
She underwent bilateral globus pallidus interna (GPi) DBS surgery.
The postoperative BFMDS 1 month after surgery was 26 and decreased
to 3 within 1 year. Her current CGI is 1. At 4 years postoperatively, her
BFMDS remains at 3, and her current settings are left GPi, 3.6 V/180
pulse width (PW)/60 Hz/1-2-C+; and right GPi, 3.6 V/180 PW/65
Hz/1-2-C+.
Discussion
DBS improves MD with reductions in BFMDS scores from approxi-
mately 14% to 97%, typically using high-frequency pallidal stimula-
tion.1–12 Improvements in the Unified Myoclonus Rating Scale also
improved from 11% to 100%.1–12 Our patient had a reduction in her
BFMDS by 96% with low-frequency, high pulse width pallidal stimu-
lation, similar to two recent cases of MD that responded to 60 Hz
pallidal stimulation.13 Unlike these recent cases, however, our case was
not positive for the SGCE gene, yet demonstrated a robust reduction
in clinical severity, as seen in the reduction of her CGI from 7 to 1.
Thus, ours is the first report of a sarcoglycan mutation-negative case to
respond well to low-frequency, high pulse width pallidal stimulation.
Despite the presence of epsilon sarcoglycan in the basal ganglia,
cerebellum, and hippocampi of animals, the role of a mutation in this
gene in the development of MD is unknown. In addition, the patho-
mechanisms of newly discovered gene loci in disease development are
also unknown.1,2 Thus, despite the presence of this gene mutation in
many previously reported DBS cases, the positive response in both
cases with and without this mutation,1,2 like ours, and the small
number of total MD cases with DBS suggest that, at this time, it is
difficult to utilize gene status in predicting surgical outcomes, unlike in
those with DYT-1 or DYT-6 mutations.14 It is possible, however, that
those without the mutation may have only a moderate reduction in
myoclonus compared with those with positive mutation status,1 but as
seen in our report the myoclonus may respond in mutation-negative
patients with low-frequency stimulation.
We did not attempt high-frequency stimulation in our case. We base
our programming paradigm on our center’s extensive experience with
low-frequency stimulation in DYT-1-positive patients.15,16 The lower
frequency allows more posteriorventral contacts to be used, providing
more programming options and fewer side effects. Our case responded
robustly to low frequency from the beginning without significant
adverse effects, mitigating any need to attempt high frequency stimu-
lation. Also, the low-frequency stimulation may approximate the intra-
operative firing rate of the target neurons.15 Thus, a frequency higher
than what is recorded intraoperatively may not be necessary in treating
dystonia. Apart from DYT-1, we have also shown that low-frequency
stimulation can provide relief in other dystonia syndromes, including X-
linked dystonia Parkinsonism17 and ADCY5-related hyperkinetic move-
ment disorder syndrome with dystonia, myoclonus, and chorea.18
Thus, our case further supports the utility of low-frequency GPi
DBS for MD as an effective therapeutic option not only in epsilon
sarcoglycan-positive cases but in those without the mutation. Further
study is needed to determine the role of mutation status in predicting
DBS response as in other dystonia syndromes, such as DYT-1.
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